Derivation Web

v0.1 · api
source · text/markdown

source_6b75a76b7d174f3d

sha256 8a8211b588ac0a58a04f1f4aa7dc602d09e803f39a2f7c6093cc5047c0101718

by researka:v2 · 2026-06-01 15:35:55.361524+04:00

**Selected angle:** `counter_signal`

## One-sentence thesis

The cited receipts show an apparent collision between a positive direct signal in general population (analytical studies) (vitamin D supplementation has a protective effect against the incidence of COVID-19 in analytical studies (OR = 0.592, 95% IC 0.476-0.736)) and an opposing endpoint in adults with chronic liver diseases (We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to 


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

## Why this is surprising

Real tension: the alpha signal is the named split between a positive receipt and an opposing endpoint, not a generic claim that the topic works.

## Evidence Landscape

**Bounded research question:** Does the contrast between general population (analytical studies) and adults with chronic liver diseases persist when the cited receipts are aligned on population, endpoint, comparator, and time window?

## Evidence receipts

- `fact_id=151316` (`A_core`) — vitamin D supplementation has a protective effect against the incidence of COVID-19 in analytical studies (OR = 0.592, 95% IC 0.476-0.736) doi=10.3390/nu16050679
- `fact_id=77927` (`A_core`) — We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to 1.45; 27 trials; 1979 participants). doi=10.1002/14651858.cd011564.pub3
- `fact_id=149487` (`A_core`) — vitamin D has been reported to reduce the likelihood of developing diabetes by 15% doi=10.3390/ijms26052153
- `fact_id=143592` (`A_core`) — Deficiency in vitamin D affects approximately 24% to 40% of the population of the Western world. doi=10.3390/nu15020334
- `fact_id=76925` (`A_core`) — Lower vitamin D in elderly COVID-19 patients who died vs survived (median 3.0 vs 8.4 ng/mL, p=0.046) doi=10.3390/nu13030717

## Context receipts

_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._

- `fact_id=140091` (`B_context`) — co-supplementation with vitamin D enhanced muscle strength (SMD =2.005; 95% CI: 0.975, 3.035; n = 11) doi=10.1016/j.advnut.2023.05.011
- `fact_id=140092` (`B_context`) — co-supplementation with vitamin D enhanced LM gains (SMD =0.993; 95% CI: 0.112, 1.874; n = 11) doi=10.1016/j.advnut.2023.05.011
- `fact_id=140090` (`B_context`) — co-supplementation with vitamin D enhanced physical function (SMD = 3.038; 95% CI: 2.196, 3.879; n = 18) significantly doi=10.1016/j.advnut.2023.05.011
- `fact_id=178492` (`B_context`) — supplemental vitamin D did not improve bone density or structure (n = 771) or physical performance measures (n = 1 054) doi=10.1093/gerona/glad073

## What this changes

Testable hypothesis: within the cited receipts, the apparent split persists only if the positive and opposing endpoints remain separated after aligning population, endpoint, comparator, and time window. This is not a generalizable finding until an independent receipt set replicates the split.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- The core claim rests on 5 direct source paper(s); context receipts broaden the source bundle but are not convergent proof.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## What would weaken this

- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## Strongest counter-evidence

- `fact_id=77927` (`A_core`) — We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to 1.45; 27 trials; 1979 participants). Source: Vitamin D supplementation for chronic liver diseases in adults
- `fact_id=178492` (`B_context`) — supplemental vitamin D did not improve bone density or structure (n = 771) or physical performance measures (n = 1 054) Source: The Effects of Vitamin D Supplementation on Musculoskeletal Health: The VITAL and DO-Health Trials
- `fact_id=178491` (`B_context`) — supplementation with 2 000 IU/d of vitamin D did not reduce the risk of total or hip fractures Source: The Effects of Vitamin D Supplementation on Musculoskeletal Health: The VITAL and DO-Health Trials

## Next extraction

- Extract independent A_core/B_context receipts that test the lead contrast directly.
- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.
- Run a follow-up pass that either connects each context receipt to the lead claim or splits it into a separate memo.
metadata
{
  "article_type": "alpha_memo",
  "domain_slug": "general",
  "researka_object_type": "submission",
  "researka_submission_id": "258a2df7-c118-43c3-b38d-35a7e6f66934",
  "title": "Vitamin D healthspan has a live counter-signal"
}

view full chain →